Cogent Biosciences annual revenue
2017
2018
2019
2020
2022
2023
2024
2025
Cogent Biosciences Revenue Growth & History (COGT)
Cogent Biosciences reported $0 in revenue for fiscal 2025.
View full Cogent Biosciences company overviewCogent Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
| 2020 | 2020-12-31 | $7.9M | −$14.6M | −65.02% |
| 2019 | 2019-12-31 | $22.5M | $12.8M | +131.14% |
| 2018 | 2018-12-31 | $9.7M | $1.4M | +16.44% |
| 2017 | 2017-12-31 | $8.4M | — | — |
Cogent Biosciences quarterly revenue
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2020 | 2020-12-31 | $0 | −$15.3M | −100.00% |
| Q3 2020 | 2020-09-30 | $312,000 | −$708,000 | −69.41% |
| Q2 2020 | 2020-06-30 | $528,000 | −$2.6M | −83.17% |
| Q1 2020 | 2020-03-31 | $7.0M | $4.0M | +130.30% |
| Q4 2019 | 2019-12-31 | $15.3M | $11.5M | +301.79% |
| Q3 2019 | 2019-09-30 | $1.0M | −$1.0M | −50.07% |
| Q2 2019 | 2019-06-30 | $3.1M | $1.5M | +88.36% |
| Q1 2019 | 2019-03-31 | $3.1M | $833,000 | +37.52% |
| Q4 2018 | 2018-12-31 | $3.8M | $1.7M | +79.23% |
| Q3 2018 | 2018-09-30 | $2.0M | −$288,000 | −12.36% |
| Q2 2018 | 2018-06-30 | $1.7M | −$413,000 | −19.87% |
| Q1 2018 | 2018-03-31 | $2.2M | $393,000 | +21.51% |
| Q4 2017 | 2017-12-31 | $2.1M | — | — |
| Q3 2017 | 2017-09-30 | $2.3M | — | — |
| Q2 2017 | 2017-06-30 | $2.1M | — | — |
| Q1 2017 | 2017-03-31 | $1.8M | — | — |
Cogent Biosciences revenue growth trends
Cogent Biosciences's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Cogent Biosciences source filings ↗